Daniel K. Spiegelman, EVP, Chief Financial Officer at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 35,000 shares at $94.00 ($3.3M) on 2017-02-28, disclosed to the SEC on 2017-03-02.
Seasonal sale ($3.3M) by EVP, Chief Financial Officer — this insider has traded BMRN in February in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $94.00 | 30,000 | $2.8M | 85.6% |
| 2 | $94.50 | 5,000 | $473K | 14.4% |
| Total | $94.07 avg | 35,000 | $3.3M | 100% |
| Filing → |
| MYGN | SELL | 2022-06-06 | $124K | — | Filing → |
| MYGN | SELL | 2021-06-17 | $192K | — | Filing → |
| MYGN | SELL | 2021-06-01 | $414K | — | Filing → |